The PRECAMA study is a large, multicentre case-control study in Latin America, coordinated by the Section of Nutrition and Metabolism at the International Agency for Research on Cancer (IARC). This study aims to advance the prevention and management of breast cancer in countries in epidemiological transition in Latin America, through a better understanding of the molecular, pathological, and risk factor patterns.
The role of moderate- to high-risk breast cancer susceptibility genes is being studied and basic knowledge of genetic counselling is fundamental to study high penetrance mutation genes. For this reason, IARC and the Hospital Sírio-Libanês in Brazil have developed this series of webinars “Introduction on Genetic Counselling for Cancer Predisposition Syndromes“, targeting institutions involved in PRECAMA, as well as other institutions in Latin America.
This webinar series is meant to provide basic information and awareness to health professionals on genetic counselling for cancer predisposition syndromes. With this purpose in mind, eight webinars, of approximately 40 minutes each, have been developed by two experts from the Hospital Sírio-Libanês, Dr Maria Isabel Achatz and Dr Renata Sandoval. The series, broadcasted and recorded in English during October and December 2019, and can be found on IARC WebTV.
|Dr Maria Isabel Achatz||Dr Renata Lazari Sandoval|
“The content of this webinar series helped me to understand the surface of genetic counselling. I believe it will help me to connect some of my patients with appropriate multidisciplinary treatment team when necessary”. Dr Claudia Carvajal, Radiation Oncologist, Instituto Nacional del Cancer, Chile
Acknowledgements: to Dr Maria Isabel Achatz and Dr Renata Lazari Sandoval, Hospital Sírio-Libanês, Dr Sabina Rinaldi, Ms Anouk Berger, Dr Mathilde His, Ms Silvia Lesage and Ms Sandrine Montigny (IARC).